Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes
Authors' conclusion
Beta cell dysfunction and lipodystrophy could be the driving pathological pathways in type 2 diabetes in individuals with normal weight. Genetic risks of beta cell dysfunction and obesity represent two major genetic drivers of type 2 diabetes heterogeneity in disease progression and diabetic complications, which are shared across ancestry groups. Type 2 diabetes psPRSs may help inform patient stratification according to aetiology and guide precision diabetes care.
Study context
- Population
- Chinese patients with T2D from Hong Kong
- Participants
- 18,217 patients
- Exposure
- Pathway-specific polygenic risk scores (psPRSs) and total T2D polygenic risk score (PRS) vs clinical profile and outcomes
- Outcome
- Associations of psPRSs with onset, progression and complications
Methodological detailspathway-specific polygenic risk scores, hard-clustering and soft-clustering, Total T2D PRS summed by genome-wide significant T2D signals (n=1289)
- Pathway-specific polygenic risk scores
- Hard-clustering and soft-clustering
- Total T2D PRS summed by genome-wide significant T2D signals (n=1289)
Main finding
As reported in the abstract
- psPRS obesity: clinical requirement of insulin treatment, aHR
- 1.09 [1.05, 1.13], p<0.0001 (95% CI)
- psPRS obesity: end-stage renal disease, aHR
- 1.10 [1.04, 1.16], p=0.0007 (95% CI)
- psPRS obesity: CVD, aHR
- 1.10 [1.05, 1.16], p<0.0001 (95% CI)
- psPRS beta cell dysfunction: reduced incident end-stage renal disease, aHR
- 0.90 [0.85, 0.95], p=0.0001 (95% CI)
- psPRS beta cell dysfunction: reduced HF, aHR
- 0.83 [0.73, 0.93], p=0.0011 (95% CI)
Observational data: associations, not effects.
Original publication
Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes. Diabetologia. Published 12 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →